The National Horsemen’s Benevolent and Protective Association (HBPA) has adopted a position on medication and drug testing that states any changes in policies in each jurisdiction should be enacted only after there is scientific evidence that specific therapeutic drugs shouldn’t be used in racehorses.

The National HBPA supports efforts by the national Racing Medication and Testing Consortium to create a uniform policy for the country. However, the consortium has taken a somewhat different position in that it believes the industry must first scientifically prove drugs should be used in horses before their use is permitted